Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feifei Teng

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Journal of Cancer Research and Clinical Oncology|December 8, 2021
Correction to: Efficacy of single-site radiotherapy plus PD-1 inhibitors vs PD-1 inhibitors for oligometastatic non-small cell lung cancerPeiliang Wang, Tianwen Yin, Kaikai Zhao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 25, 2017
Blood-tumor barrier opening changes in brain metastases from pre to one-month post radiation therapyFeifei Teng, Christina I Tsien, Theodore S Lawrence, et al.
Cancer Biology & Therapy|March 8, 2017
Abscopal effect of metastatic pancreatic cancer after local radiotherapy and granulocyte-macrophage colony-stimulating factor therapyFang Shi, Xin Wang, Feifei Teng, et al.
Cancer Management and Research|April 10, 2019
Primary tumor location is an important predictor of survival in pulmonary adenocarcinomaZhe Wang, Minghuan Li, Feifei Teng, et al.
Cancer Treatment Reviews|November 22, 2015
Predictive biomarkers in PD-1/PD-L1 checkpoint blockade immunotherapyXiangjiao Meng, Zhaoqin Huang, Feifei Teng, et al.
BMC Cancer|May 12, 2025
The impact of EGFR mutation and PD-L1 status on the efficacy of postoperative radiotherapy in stage III-pN2 NSCLCJinquan Yao, Yuxin Geng, Junhao Xu, et al.
Cancer Letters|May 19, 2015
Radiotherapy combined with immune checkpoint blockade immunotherapy: Achievements and challengesFeifei Teng, Li Kong, Xiangjiao Meng, et al.
Cancer Science|October 7, 2021
Prediction of the effects of radiation therapy in esophageal cancer using diffusion and perfusion MRIPeiliang Wang, Xin Wang, Liang Xu, et al.
Journal of Cancer Research and Clinical Oncology|August 15, 2019
Metastatic location of extensive stage small-cell lung cancer: implications for thoracic radiationHuaqi Zhang, Lei Deng, Xin Wang, et al.
Oncoimmunology|February 12, 2024
Noninvasive radiomic biomarkers for predicting pseudoprogression and hyperprogression in patients with non-small cell lung cancer treated with immune checkpoint inhibitionYikun Li, Peiliang Wang, Junhao Xu, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Journal of Cancer Research and Clinical Oncology|December 8, 2021
Correction to: Efficacy of single-site radiotherapy plus PD-1 inhibitors vs PD-1 inhibitors for oligometastatic non-small cell lung cancerPeiliang Wang, Tianwen Yin, Kaikai Zhao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 25, 2017
Blood-tumor barrier opening changes in brain metastases from pre to one-month post radiation therapyFeifei Teng, Christina I Tsien, Theodore S Lawrence, et al.
Cancer Biology & Therapy|March 8, 2017
Abscopal effect of metastatic pancreatic cancer after local radiotherapy and granulocyte-macrophage colony-stimulating factor therapyFang Shi, Xin Wang, Feifei Teng, et al.
Cancer Management and Research|April 10, 2019
Primary tumor location is an important predictor of survival in pulmonary adenocarcinomaZhe Wang, Minghuan Li, Feifei Teng, et al.
Cancer Treatment Reviews|November 22, 2015
Predictive biomarkers in PD-1/PD-L1 checkpoint blockade immunotherapyXiangjiao Meng, Zhaoqin Huang, Feifei Teng, et al.
BMC Cancer|May 12, 2025
The impact of EGFR mutation and PD-L1 status on the efficacy of postoperative radiotherapy in stage III-pN2 NSCLCJinquan Yao, Yuxin Geng, Junhao Xu, et al.
Cancer Letters|May 19, 2015
Radiotherapy combined with immune checkpoint blockade immunotherapy: Achievements and challengesFeifei Teng, Li Kong, Xiangjiao Meng, et al.
Cancer Science|October 7, 2021
Prediction of the effects of radiation therapy in esophageal cancer using diffusion and perfusion MRIPeiliang Wang, Xin Wang, Liang Xu, et al.
Journal of Cancer Research and Clinical Oncology|August 15, 2019
Metastatic location of extensive stage small-cell lung cancer: implications for thoracic radiationHuaqi Zhang, Lei Deng, Xin Wang, et al.
Oncoimmunology|February 12, 2024
Noninvasive radiomic biomarkers for predicting pseudoprogression and hyperprogression in patients with non-small cell lung cancer treated with immune checkpoint inhibitionYikun Li, Peiliang Wang, Junhao Xu, et al.
Pageof 6